Page last updated: 2024-08-18

4-butyrolactone and Cancer of Kidney

4-butyrolactone has been researched along with Cancer of Kidney in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (50.00)18.2507
2000's3 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goto, T; Hosaka, Y; Kasuya, Y; Kitamura, T; Matsushima, H; Okuyama, A1
Liu, G; Wang, W; Zheng, J1
Gu, Z; Hopp, DC; McLaughlin, JL; Zeng, L1
Cadman, TB; Degregorio, MW; Hammock, BD; Jones, AD; Wurz, GT; Zheng, J1
Basaki, Y; Chikahisa, L; Hashimoto, A; Miyadera, K; Okabe, S; Wierzba, K; Yamada, Y; Yonekura, K1
Aoyagi, K; Basaki, Y; Chikahisa, L; Hashimoto, A; Miyadera, K; Okabe, S; Yamada, Y; Yonekura, K1

Other Studies

6 other study(ies) available for 4-butyrolactone and Cancer of Kidney

ArticleYear
Prominent induction of cyclin B1 in G2/M renal cancer cells with butyrolactone 1.
    International journal of urology : official journal of the Japanese Urological Association, 2003, Volume: 10, Issue:6

    Topics: 4-Butyrolactone; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Survival; Cyclin B; Cyclin B1; Cyclin-Dependent Kinases; Cyclins; DNA, Neoplasm; Enzyme Inhibitors; Humans; Kidney Neoplasms

2003
Human renal UOK130 tumor cells: a drug resistant cell line with highly selective over-expression of glutathione S-transferase-pi isozyme.
    European journal of pharmacology, 2007, Jul-30, Volume: 568, Issue:1-3

    Topics: 4-Butyrolactone; Antineoplastic Agents; Carcinoma, Renal Cell; Cell Line, Tumor; Chlorambucil; Cisplatin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Glutathione; Glutathione S-Transferase pi; Humans; Isoenzymes; Kidney Neoplasms; Melphalan; Transfection

2007
Squamotacin: an annonaceous acetogenin with cytotoxic selectivity for the human prostate tumor cell line (PC-3).
    Journal of natural products, 1996, Volume: 59, Issue:2

    Topics: 4-Butyrolactone; Animals; Antineoplastic Agents, Phytogenic; Artemia; Breast Neoplasms; Colonic Neoplasms; Humans; Kidney Neoplasms; Lung Neoplasms; Male; Pancreatic Neoplasms; Plants, Medicinal; Prostatic Neoplasms; Tumor Cells, Cultured

1996
Haloenol lactone: a new synergist of chemotherapy in vitro.
    Biochemical and biophysical research communications, 1997, Dec-08, Volume: 241, Issue:1

    Topics: 4-Butyrolactone; Antineoplastic Agents; Cell Survival; Cisplatin; Drug Synergism; Enzyme Inhibitors; Glutathione Transferase; Humans; Isoenzymes; Kidney Neoplasms; Kinetics; Tumor Cells, Cultured

1997
UFT and its metabolites inhibit the angiogenesis induced by murine renal cell carcinoma, as determined by a dorsal air sac assay in mice.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1999, Volume: 5, Issue:8

    Topics: 4-Butyrolactone; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cell Division; Diffusion Chambers, Culture; Dose-Response Relationship, Drug; Floxuridine; Fluorouracil; Hydroxybutyrates; Kidney Neoplasms; Male; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neovascularization, Pathologic; Tegafur; Tumor Cells, Cultured; Uracil

1999
[Anti-angiogenic activities of UFT and its metabolites, GHB and GBL, in the dorsal air sac (DAS) model in mice].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2000, Volume: 27, Issue:1

    Topics: 4-Butyrolactone; Animals; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Kidney Neoplasms; Lung Neoplasms; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Sodium Oxybate; Stomach Neoplasms; Tegafur; Tumor Cells, Cultured; Uracil

2000